Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1194

1.

Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.

Tamimi RM, Hankinson SE, Chen WY, Rosner B, Colditz GA.

Arch Intern Med. 2006 Jul 24;166(14):1483-9.

PMID:
16864758
2.

Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.

Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2005 Apr 20;97(8):595-602.

PMID:
15840882
3.

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.

Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE.

N Engl J Med. 1995 Jun 15;332(24):1589-93.

4.

Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy.

Dimitrakakis C, Jones RA, Liu A, Bondy CA.

Menopause. 2004 Sep-Oct;11(5):531-5.

PMID:
15356405
5.

Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study.

Colditz GA, Stampfer MJ, Willett WC, Hunter DJ, Manson JE, Hennekens CH, Rosner BA, Speizer FE.

Cancer Causes Control. 1992 Sep;3(5):433-9.

PMID:
1525324
6.

Unopposed estrogen therapy and the risk of invasive breast cancer.

Chen WY, Manson JE, Hankinson SE, Rosner B, Holmes MD, Willett WC, Colditz GA.

Arch Intern Med. 2006 May 8;166(9):1027-32.

PMID:
16682578
7.

Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States.

Willis DB, Calle EE, Miracle-McMahill HL, Heath CW Jr.

Cancer Causes Control. 1996 Jul;7(4):449-57.

PMID:
8813433
8.

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE.

J Natl Cancer Inst. 1998 Sep 2;90(17):1292-9.

PMID:
9731736
9.

Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women.

de Lignières B, de Vathaire F, Fournier S, Urbinelli R, Allaert F, Le MG, Kuttenn F.

Climacteric. 2002 Dec;5(4):332-40.

PMID:
12626212
10.

Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer.

Jick SS, Hagberg KW, Kaye JA, Jick H.

Obstet Gynecol. 2009 Jan;113(1):74-80. doi: 10.1097/AOG.0b013e31818fdde4.

PMID:
19104362
11.

Use of postmenopausal hormones, alcohol, and risk for invasive breast cancer.

Chen WY, Colditz GA, Rosner B, Hankinson SE, Hunter DJ, Manson JE, Stampfer MJ, Willett WC, Speizer FE.

Ann Intern Med. 2002 Nov 19;137(10):798-804.

PMID:
12435216
12.

Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype.

Calle EE, Feigelson HS, Hildebrand JS, Teras LR, Thun MJ, Rodriguez C.

Cancer. 2009 Mar 1;115(5):936-45. doi: 10.1002/cncr.24101. Erratum in: Cancer. 2009 Apr 1;115(7):1587.

13.

Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.

Colditz GA.

J Natl Cancer Inst. 1998 Jun 3;90(11):814-23. Review.

PMID:
9625169
14.

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

PMID:
15601642
15.

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.

Maturitas. 2006 Sep 20;55(2):103-15. Epub 2006 Jul 11.

PMID:
16815651
16.

Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.

Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.

J Natl Cancer Inst. 2006 Oct 4;98(19):1406-15.

PMID:
17018787
17.

Estrogen-progestin replacement therapy and breast cancer risk: the Women's Health Study (United States).

Porch JV, Lee IM, Cook NR, Rexrode KM, Burin JE.

Cancer Causes Control. 2002 Nov;13(9):847-54.

PMID:
12462550
18.

Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.

Kerlikowske K, Miglioretti DL, Ballard-Barbash R, Weaver DL, Buist DS, Barlow WE, Cutter G, Geller BM, Yankaskas B, Taplin SH, Carney PA.

J Clin Oncol. 2003 Dec 1;21(23):4314-21.

PMID:
14645420
19.

Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.

Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G, Berlin JA, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Wingo PA, Spirtas R.

Cancer. 2002 Dec 15;95(12):2455-64.

20.

Risk factors for breast cancer according to estrogen and progesterone receptor status.

Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE.

J Natl Cancer Inst. 2004 Feb 4;96(3):218-28.

PMID:
14759989

Supplemental Content

Support Center